COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Guidelines for the use of interferon-γ release assays in the diagnosis of tuber...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Consensus statement
Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection
Guía de práctica clínica sobre el uso de las pruebas de liberación de interferón-γ para el diagnóstico de infección tuberculosa
Panel of experts from the Mycobacteria Study Group (GEIM) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Respiratory Diseases and Thoracic Surgery (SEPAR) 2, Miguel Santina,b,1, José-María García-Garcíac,1, José Domínguezd,e,f,1,
Corresponding author
jadomb@gmail.com

Corresponding author.
a Service of Infectious Diseases, Bellvitge University Hospital-IDIBELL, Barcelona, Spain
b Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
c Clinical Unit of Pneumology, Hospital San Agustín, Avilés, Asturias, Spain
d Service of Microbiology, Research Institute Trias i Pujol, Hospital Gremans Trias i Pujol, Barcelona, Spain
e Department of Genetics and Microbiology, Universidad Autónoma de Barcelona, Barcelona, Spain
f CIBER Respiratory Diseases, Madrid, Spain
Read
10202
Times
was read the article
2381
Total PDF
7821
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2015.11.022
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 111 29 140
2024 March 130 36 166
2024 February 122 30 152
2024 January 197 31 228
2023 December 122 49 171
2023 November 141 46 187
2023 October 151 43 194
2023 September 117 42 159
2023 August 101 19 120
2023 July 147 54 201
2023 June 169 17 186
2023 May 157 15 172
2023 April 92 18 110
2023 March 93 16 109
2023 February 71 23 94
2023 January 80 23 103
2022 December 126 31 157
2022 November 113 42 155
2022 October 76 21 97
2022 September 77 29 106
2022 August 80 27 107
2022 July 54 20 74
2022 June 74 23 97
2022 May 65 25 90
2022 April 51 31 82
2022 March 106 32 138
2022 February 78 42 120
2022 January 110 24 134
2021 December 74 30 104
2021 November 66 30 96
2021 October 94 22 116
2021 September 52 16 68
2021 August 73 12 85
2021 July 61 17 78
2021 June 71 31 102
2021 May 73 18 91
2021 April 137 75 212
2021 March 73 31 104
2021 February 84 35 119
2021 January 91 19 110
2020 December 64 15 79
2020 November 68 22 90
2020 October 57 27 84
2020 September 87 19 106
2020 August 72 31 103
2020 July 112 14 126
2020 June 81 28 109
2020 May 59 25 84
2020 April 59 22 81
2020 March 95 20 115
2020 February 74 18 92
2020 January 66 33 99
2019 December 107 41 148
2019 November 60 36 96
2019 October 134 23 157
2019 September 96 43 139
2019 August 67 18 85
2019 July 97 49 146
2019 June 131 49 180
2019 May 275 109 384
2019 April 99 34 133
2019 March 55 21 76
2019 February 55 23 78
2019 January 28 13 41
2018 December 35 15 50
2018 November 66 27 93
2018 October 64 22 86
2018 September 30 10 40
2018 August 16 13 29
2018 July 31 15 46
2018 June 71 4 75
2018 May 34 12 46
2018 April 39 10 49
2018 March 36 3 39
2018 February 36 5 41
2018 January 40 6 46
2017 December 29 9 38
2017 November 40 9 49
2017 October 34 9 43
2017 September 31 10 41
2017 August 35 10 45
2017 July 41 6 47
2017 June 55 19 74
2017 May 36 12 48
2017 April 46 8 54
2017 March 50 49 99
2017 February 36 14 50
2017 January 40 2 42
2016 December 52 15 67
2016 November 56 18 74
2016 October 116 12 128
2016 September 100 39 139
2016 August 70 40 110
2016 July 79 23 102
2016 June 135 8 143
2016 May 80 17 97
2016 April 104 3 107
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos